1h Free Analyst Time
The global benign prostatic hyperplasia (bph) devices market is forecasted to grow by USD 3.28 billion during 2025-2030, accelerating at a CAGR of 4.6% during the forecast period. The report on the global benign prostatic hyperplasia (bph) devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by shift toward minimally invasive surgical therapies (mists) and office-based interventions, integration of artificial intelligence and robotics in surgical resection, expansion of reimbursement coverage and coding infrastructure.
The study identifies the integration of artificial intelligence and robotic precision as one of the prime reasons driving the global benign prostatic hyperplasia (bph) devices market growth during the next few years. Also, migration toward office-based and ambulatory care models and prioritization of sexual function preservation will lead to sizable demand in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global benign prostatic hyperplasia (bph) devices market is segmented as below:
By Therapy
- TURP
- Laser therapy
- Others
By Type
- Invasive surgery
- Minimal invasive surgery
By End-User
- Hospitals
- Specialty facilities
- Research and manufacturing
By Region
- North America
- Europe
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report covers the following areas:
- Global benign prostatic hyperplasia (bph) devices market sizing
- Global benign prostatic hyperplasia (bph) devices market forecast
- Global benign prostatic hyperplasia (bph) devices market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Therapy
9 Market Segmentation by Type
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global global benign prostatic hyperplasia (bph) devices market: biolitec AG, Boston Scientific Corp., Coloplast AS, CONMED Corp., Cook Group Inc., Dornier MedTech GmbH, ForTec Medical, KARL STORZ SE and Co. KG, Laborie, Lumenis Be Ltd., Medtronic Plc, Olympus Corp., OmniGuide Holdings Inc., Pnn Medical AS, PROCEPT BioRobotics Corp., Quanta System S.p.A., Richard Wolf GmbH, SonaCare Medical LLC, Teleflex Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of artificial intelligence and robotic precision."
According to the report, one of the major drivers for this market is the shift toward minimally invasive surgical therapies (mists) and office-based interventions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- biolitec AG
- Boston Scientific Corp.
- Coloplast AS
- CONMED Corp.
- Cook Group Inc.
- Dornier MedTech GmbH
- ForTec Medical
- KARL STORZ SE and Co. KG
- Laborie
- Lumenis Be Ltd.
- Medtronic PLC
- Olympus Corp.
- OmniGuide Holdings Inc.
- Pnn Medical AS
- PROCEPT BioRobotics Corp.
- Quanta System S.p.A.
- Richard Wolf GmbH
- SonaCare Medical LLC
- Teleflex Inc.
